antiparkinson
Sign in to saveAlso known as antiparkinson agent, antiparkinsonians, antiparkinsonian agents, antiparkinson drugs, management of Parkinson's disease, pharmacological treatment of Parkinson's disease
agents used in the treatment of parkinson's disease
Research
13,799 papers- [ANTIPARKINSON DRUGS].Bollettino chimico farmaceutico · 1965
- L-DOPA.Journal of Parkinson's disease · 2017
- Prophylactic antiparkinson drug use: II. Withdrawal after long-term maintenance therapy.Journal of clinical pharmacology · 1991
- Prophylactic antiparkinson drug use: I. Initial prophylaxis and prevention of extrapyramidal side effects.Journal of clinical pharmacology · 1991
- Antiparkinson drugs in paranoid schizophrenia.North Carolina medical journal · 1979
via PubMed
Clinical Trials
6 registered- PHASE2COMPLETEDPharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.University of California, San Diego · NCT02634684
- SUSPENDEDClinical Characteristics of Parkinson's Disease Subjects With Severe Hypertension During Motor OFFs.Oregon Health and Science University · NCT03433950
- PHASE2COMPLETEDDopaminergic Dysfunction in Late-Life DepressionVanderbilt University Medical Center · NCT04469959
- ACTIVE_NOT_RECRUITINGLong-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's DiseaseBritannia Pharmaceuticals Ltd. · NCT05043103
- PHASE1/PHASE2TERMINATEDRelative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral RopiniroleTitan Pharmaceuticals · NCT03250117
- PHASE2RECRUITINGPimavanserin for Rigid-compulsive Symptoms in Autism Spectrum DisorderNew York State Psychiatric Institute · NCT05999240
Wikidata facts
- Instance of
- medication
Show 2 more facts
- medical condition treated
- Parkinson's disease
- topic's main category
- Category:Antiparkinsonian agents
Sources (1)
via Wikidata · CC0